Qiagen (NYSE:QGEN) Updates Q1 2025 Earnings Guidance

Qiagen (NYSE:QGEN) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.500- for the period, compared to the consensus estimate of 0.500. The company issued revenue guidance of $472.8 million-, compared to the consensus revenue estimate of $477.5 million. Qiagen also updated its FY 2025 guidance to 2.280- EPS.

Analyst Ratings Changes

Several research analysts recently weighed in on QGEN shares. Hsbc Global Res upgraded Qiagen to a “hold” rating in a research note on Thursday, October 17th. HSBC cut Qiagen from a “buy” rating to a “hold” rating and set a $47.64 target price for the company. in a research note on Thursday, October 17th. Jefferies Financial Group reiterated a “buy” rating and issued a $52.50 price objective (up previously from $40.83) on shares of Qiagen in a report on Tuesday, December 10th. Morgan Stanley reiterated an “equal weight” rating and issued a $46.67 price target (down previously from $48.61) on shares of Qiagen in a research note on Monday, January 6th. Finally, UBS Group reduced their price target on shares of Qiagen from $50.00 to $48.00 and set a “neutral” rating for the company in a research report on Friday. Five analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $49.84.

Qiagen Trading Down 3.3 %

QGEN stock traded down $1.41 during trading on Friday, reaching $41.03. 531,564 shares of the stock traded hands, compared to its average volume of 1,204,042. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.17 and a quick ratio of 1.89. The firm has a market capitalization of $9.10 billion, a PE ratio of 102.16, a P/E/G ratio of 3.10 and a beta of 0.36. The business’s 50 day moving average price is $43.80 and its 200-day moving average price is $43.25. Qiagen has a 52-week low of $40.15 and a 52-week high of $49.30.

Qiagen (NYSE:QGEN) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.01. Qiagen had a return on equity of 13.43% and a net margin of 4.73%. As a group, sell-side analysts forecast that Qiagen will post 2.23 earnings per share for the current year.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.